Syngene International Limited, commonly referred to as Syngene, is a prominent player in the health and social work services sector, with its headquarters based in India. Established in 1997, the company has grown significantly over the years, becoming a key provider of integrated research and development services for the global pharmaceutical, biotech, and consumer health industries.
Specialising in contract research, development, and manufacturing, Syngene offers a wide range of innovative solutions that support drug discovery, development, and manufacturing processes. Its strategic presence across major regions enables it to serve a diverse international client base, earning recognition for its scientific expertise and quality standards. As a leader in its field, Syngene continues to advance healthcare innovation through its comprehensive service offerings and commitment to excellence.
+40 vs industry average
Syngene’s score of 63 is higher than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Syngene?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Health Services has typical carbon intensity
Industry performance
The Health Services industry has reduced its overall emissions by 23% since 2018
Emissions trajectory 2020 – 2028
Reported emissions
Scope 3 accounts for ••• of total emissions.
Syngene's reported carbon emissions
Syngene International Limited's latest reported greenhouse gas emissions are from its fiscal year 2023, with a total of approximately 109.1 million kg CO2e. This total comprises Scope 1 emissions of about 6 million kg CO2e, Scope 2 emissions of approximately 18.8 million kg CO2e (market-based), and Scope 3 emissions of approximately 89.4 million kg CO2e.
The company has set near-term and long-term climate targets. For near-term goals, Syngene aims to reduce its Scope 1 emissions by 30% and Scope 2 emissions by 25% from a 2021 baseline by 2030.
Syngene also has commitments aligned with the Science Based Targets initiative (SBTi). These include a commitment to reduce absolute Scope 1 and 2 greenhouse gas emissions by 54.6% by fiscal year 2033, using fiscal year 2023 as the base year. Additionally, the company commits that 81.6% of its suppliers, covering purchased goods and services, capital goods, and upstream transportation and distribution, will have science-based targets by fiscal year 2028. These SBTi targets are classified as consistent with reductions required to keep warming to 1.5°C.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Syngene’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Syngene yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisations
Syngene
Frequently asked questions
Common questions about Syngene’s sustainability data and climate commitments
Data year: 2025
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project